Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Takeda drops prostate cancer drug in phase III

Takeda drops prostate cancer drug in phase III Zytiga (abiraterone acetate), which brought in revenues of $1.7bn last year, and Astellas/Medivation's fast-growing Xtandi (enzalutamide) which pulled in almost $400m last year. ... A recent report by Decision Resources suggested Zytiga and Xtandi will

Oncology drugs under AMNOG: part two

Oncology drugs under AMNOG: part two It is important to separate observable patient-relevant outcomes from surrogate measures based on biomarker analysis or pathological assessment, even though these may overlap: for example, in the case of

Back to the future

Back to the future Likewise, J&J had a strong year - with eight of its key products, including Zytiga, Xarelto, Remicade, Stelara and Invega Sustenna/Xeplion, driving collective growth of more than $3.5bn (10

NICE won't back early use of Zytiga in prostate cancer

NICE won't back early use of Zytiga in prostate cancer Says Janssen drug should not be used prior to chemotherapy. Janssen's Zytiga should remain as a second-line therapy after chemotherapy in England and Wales, according to new recommendations from ... In its response, Janssen criticised NICE's decision not

NICE backtracks on prostate cancer drug enzalutamide

NICE backtracks on prostate cancer drug enzalutamide Janssen's rival oncology product Zytiga (abiraterone).

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...